Synthesis, SAR, and Evaluation of 4-[2,4-Difluoro-5-(cyclopropylcarbamoyl)phenylamino]pyrrolo[2,1- f][1,2,4]triazine-based VEGFR-2 kinase inhibitors
A new sub-family of pyrrolotriazine analogs was identified as the potent VEGFR-2 kinase inhibitors. Antitumor efficacy was observed with compound 37 against L2987 human lung carcinoma xenografts in athymic mice. Introduction of the 2,4-difluoro-5-(cyclopropylcarbamoyl)phenylamino group at the C-4 po...
Gespeichert in:
Veröffentlicht in: | Bioorganic & medicinal chemistry letters 2008-02, Vol.18 (4), p.1354-1358 |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | A new sub-family of pyrrolotriazine analogs was identified as the potent VEGFR-2 kinase inhibitors. Antitumor efficacy was observed with compound
37 against L2987 human lung carcinoma xenografts in athymic mice.
Introduction of the 2,4-difluoro-5-(cyclopropylcarbamoyl)phenylamino group at the C-4 position of the pyrrolo[2,1-
f][1,2,4] triazine scaffold led to the discovery of a novel sub-series of inhibitors of VEGFR-2 kinase activity. Subsequent SAR studies on the 1,3,5-oxadiazole ring appended to the C-6 position of this new sub-family of pyrrolotriazines resulted in the identification of low nanomolar inhibitors of VEGFR-2. Antitumor efficacy was observed with compound
37 against L2987 human lung carcinoma xenografts in athymic mice. |
---|---|
ISSN: | 0960-894X 1464-3405 |
DOI: | 10.1016/j.bmcl.2008.01.012 |